Medicago Planning Vaccine Production Facility in Durham, North Carolina
"North Carolina's quality of work force, its training programs, and overall understanding of biotech development models were critical factors in our decision to locate in RTP," said Andy Sheldon, president and CEO of Medicago. "We are thrilled with our decision to build our vaccine facility in one of the largest and successful technology parks."
Medicago has received a $21 million research grant from the Defense Advanced Research Projects Agency (DARPA) to improve the production process of H1N1 vaccines. The company's project represents a total investment of more than $32 million in Research Triangle Park.
Carver Maritime Expands Processing & Distribution Complex in North Charleston, South Carolina
A Site Selector’s Checklist for Locating in the U.S.
Location USA 2019
Where to Invest in the Booming Aerospace Manufacturing Industry
2019 Auto/Aero Site Guide
What Should High-Growth Companies Look for in a Community?
A Changing Food Manufacturing Industry
2017 Food Processing
Front Line: Trend Toward Microfactories Continues
33rd Annual Corporate Survey & the 15th Annual Consultants Survey